世界のエクソソーム診断＆治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Exosome Diagnostic and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4210 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、エクソソーム診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、ソフトウェア、試薬＆キット）、用途別市場規模（病院、がん研究所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エクソソーム診断＆治療の市場動向 ・企業の競争状況、市場シェア ・エクソソーム診断＆治療の種類別市場規模と予測2016-2027（機器、ソフトウェア、試薬＆キット） ・エクソソーム診断＆治療の用途別市場規模と予測2016-2027（病院、がん研究所、診断センター、その他） ・エクソソーム診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・エクソソーム診断＆治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エクソソーム診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エクソソーム診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・エクソソーム診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher、NanoSomix、NX PHARMAGEN、Malvern、Capricor、Exosome、Exiqon、System Biosciences、Aegle、AMS） ・結論

Market Analysis and Insights: Global Exosome Diagnostic and Therapeutics Market
The global Exosome Diagnostic and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Diagnostic and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Diagnostic and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Diagnostic and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Diagnostic and Therapeutics market.

Global Exosome Diagnostic and Therapeutics Scope and Market Size
Exosome Diagnostic and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exosome Diagnostic and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instrument
Software
Reagents and Kits

Segment by Application
Hospitals
Cancer Institutes
Diagnostic Centres
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher
NanoSomix
NX PHARMAGEN
Malvern
Capricor
Exosome
Exiqon
System Biosciences
Aegle
AMS

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instrument
1.2.3 Software
1.2.4 Reagents and Kits
1.3 Market by Application
1.3.1 Global Exosome Diagnostic and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Institutes
1.3.4 Diagnostic Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Exosome Diagnostic and Therapeutics Market Perspective (2016-2027)
2.2 Exosome Diagnostic and Therapeutics Growth Trends by Regions
2.2.1 Exosome Diagnostic and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exosome Diagnostic and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Exosome Diagnostic and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Exosome Diagnostic and Therapeutics Industry Dynamic
2.3.1 Exosome Diagnostic and Therapeutics Market Trends
2.3.2 Exosome Diagnostic and Therapeutics Market Drivers
2.3.3 Exosome Diagnostic and Therapeutics Market Challenges
2.3.4 Exosome Diagnostic and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Exosome Diagnostic and Therapeutics Players by Revenue
3.1.1 Global Top Exosome Diagnostic and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Exosome Diagnostic and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Exosome Diagnostic and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exosome Diagnostic and Therapeutics Revenue
3.4 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostic and Therapeutics Revenue in 2020
3.5 Exosome Diagnostic and Therapeutics Key Players Head office and Area Served
3.6 Key Players Exosome Diagnostic and Therapeutics Product Solution and Service
3.7 Date of Enter into Exosome Diagnostic and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Exosome Diagnostic and Therapeutics Breakdown Data by Type
4.1 Global Exosome Diagnostic and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Exosome Diagnostic and Therapeutics Breakdown Data by Application
5.1 Global Exosome Diagnostic and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Exosome Diagnostic and Therapeutics Market Size (2016-2027)
6.2 North America Exosome Diagnostic and Therapeutics Market Size by Type
6.2.1 North America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2027)
6.3 North America Exosome Diagnostic and Therapeutics Market Size by Application
6.3.1 North America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2027)
6.4 North America Exosome Diagnostic and Therapeutics Market Size by Country
6.4.1 North America Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Exosome Diagnostic and Therapeutics Market Size (2016-2027)
7.2 Europe Exosome Diagnostic and Therapeutics Market Size by Type
7.2.1 Europe Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Exosome Diagnostic and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Exosome Diagnostic and Therapeutics Market Size by Application
7.3.1 Europe Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Exosome Diagnostic and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Exosome Diagnostic and Therapeutics Market Size by Country
7.4.1 Europe Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Exosome Diagnostic and Therapeutics Market Size (2016-2027)
9.2 Latin America Exosome Diagnostic and Therapeutics Market Size by Type
9.2.1 Latin America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Exosome Diagnostic and Therapeutics Market Size by Application
9.3.1 Latin America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Exosome Diagnostic and Therapeutics Market Size by Country
9.4.1 Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Introduction
11.1.4 Thermo Fisher Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.1.5 Thermo Fisher Recent Development
11.2 NanoSomix
11.2.1 NanoSomix Company Details
11.2.2 NanoSomix Business Overview
11.2.3 NanoSomix Exosome Diagnostic and Therapeutics Introduction
11.2.4 NanoSomix Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.2.5 NanoSomix Recent Development
11.3 NX PHARMAGEN
11.3.1 NX PHARMAGEN Company Details
11.3.2 NX PHARMAGEN Business Overview
11.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Introduction
11.3.4 NX PHARMAGEN Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.3.5 NX PHARMAGEN Recent Development
11.4 Malvern
11.4.1 Malvern Company Details
11.4.2 Malvern Business Overview
11.4.3 Malvern Exosome Diagnostic and Therapeutics Introduction
11.4.4 Malvern Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.4.5 Malvern Recent Development
11.5 Capricor
11.5.1 Capricor Company Details
11.5.2 Capricor Business Overview
11.5.3 Capricor Exosome Diagnostic and Therapeutics Introduction
11.5.4 Capricor Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.5.5 Capricor Recent Development
11.6 Exosome
11.6.1 Exosome Company Details
11.6.2 Exosome Business Overview
11.6.3 Exosome Exosome Diagnostic and Therapeutics Introduction
11.6.4 Exosome Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.6.5 Exosome Recent Development
11.7 Exiqon
11.7.1 Exiqon Company Details
11.7.2 Exiqon Business Overview
11.7.3 Exiqon Exosome Diagnostic and Therapeutics Introduction
11.7.4 Exiqon Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.7.5 Exiqon Recent Development
11.8 System Biosciences
11.8.1 System Biosciences Company Details
11.8.2 System Biosciences Business Overview
11.8.3 System Biosciences Exosome Diagnostic and Therapeutics Introduction
11.8.4 System Biosciences Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.8.5 System Biosciences Recent Development
11.9 Aegle
11.9.1 Aegle Company Details
11.9.2 Aegle Business Overview
11.9.3 Aegle Exosome Diagnostic and Therapeutics Introduction
11.9.4 Aegle Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.9.5 Aegle Recent Development
11.10 AMS
11.10.1 AMS Company Details
11.10.2 AMS Business Overview
11.10.3 AMS Exosome Diagnostic and Therapeutics Introduction
11.10.4 AMS Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021)
11.10.5 AMS Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instrument
Table 3. Key Players of Software
Table 4. Key Players of Reagents and Kits
Table 5. Global Exosome Diagnostic and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exosome Diagnostic and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Exosome Diagnostic and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Exosome Diagnostic and Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Exosome Diagnostic and Therapeutics Market Share by Regions (2022-2027)
Table 11. Exosome Diagnostic and Therapeutics Market Trends
Table 12. Exosome Diagnostic and Therapeutics Market Drivers
Table 13. Exosome Diagnostic and Therapeutics Market Challenges
Table 14. Exosome Diagnostic and Therapeutics Market Restraints
Table 15. Global Exosome Diagnostic and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Exosome Diagnostic and Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Exosome Diagnostic and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostic and Therapeutics as of 2020)
Table 18. Ranking of Global Top Exosome Diagnostic and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Exosome Diagnostic and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Exosome Diagnostic and Therapeutics Product Solution and Service
Table 22. Date of Enter into Exosome Diagnostic and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Exosome Diagnostic and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Company Details
Table 63. Thermo Fisher Business Overview
Table 64. Thermo Fisher Exosome Diagnostic and Therapeutics Product
Table 65. Thermo Fisher Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Recent Development
Table 67. NanoSomix Company Details
Table 68. NanoSomix Business Overview
Table 69. NanoSomix Exosome Diagnostic and Therapeutics Product
Table 70. NanoSomix Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 71. NanoSomix Recent Development
Table 72. NX PHARMAGEN Company Details
Table 73. NX PHARMAGEN Business Overview
Table 74. NX PHARMAGEN Exosome Diagnostic and Therapeutics Product
Table 75. NX PHARMAGEN Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 76. NX PHARMAGEN Recent Development
Table 77. Malvern Company Details
Table 78. Malvern Business Overview
Table 79. Malvern Exosome Diagnostic and Therapeutics Product
Table 80. Malvern Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Malvern Recent Development
Table 82. Capricor Company Details
Table 83. Capricor Business Overview
Table 84. Capricor Exosome Diagnostic and Therapeutics Product
Table 85. Capricor Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Capricor Recent Development
Table 87. Exosome Company Details
Table 88. Exosome Business Overview
Table 89. Exosome Exosome Diagnostic and Therapeutics Product
Table 90. Exosome Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Exosome Recent Development
Table 92. Exiqon Company Details
Table 93. Exiqon Business Overview
Table 94. Exiqon Exosome Diagnostic and Therapeutics Product
Table 95. Exiqon Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Exiqon Recent Development
Table 97. System Biosciences Company Details
Table 98. System Biosciences Business Overview
Table 99. System Biosciences Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 100. System Biosciences Recent Development
Table 101. Aegle Company Details
Table 102. Aegle Business Overview
Table 103. Aegle Exosome Diagnostic and Therapeutics Product
Table 104. Aegle Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Aegle Recent Development
Table 106. AMS Company Details
Table 107. AMS Business Overview
Table 108. AMS Exosome Diagnostic and Therapeutics Product
Table 109. AMS Revenue in Exosome Diagnostic and Therapeutics Business (2016-2021) & (US$ Million)
Table 110. AMS Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Diagnostic and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Instrument Features
Figure 3. Software Features
Figure 4. Reagents and Kits Features
Figure 5. Global Exosome Diagnostic and Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Institutes Case Studies
Figure 8. Diagnostic Centres Case Studies
Figure 9. Others Case Studies
Figure 10. Exosome Diagnostic and Therapeutics Report Years Considered
Figure 11. Global Exosome Diagnostic and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Exosome Diagnostic and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Exosome Diagnostic and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Exosome Diagnostic and Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Exosome Diagnostic and Therapeutics Market Share by Players in 2020
Figure 16. Global Top Exosome Diagnostic and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostic and Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Exosome Diagnostic and Therapeutics Revenue in 2020
Figure 18. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Exosome Diagnostic and Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Exosome Diagnostic and Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Exosome Diagnostic and Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Exosome Diagnostic and Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Exosome Diagnostic and Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Exosome Diagnostic and Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Exosome Diagnostic and Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Exosome Diagnostic and Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Exosome Diagnostic and Therapeutics Market Share by Region (2016-2027)
Figure 40. China Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Exosome Diagnostic and Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Exosome Diagnostic and Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Exosome Diagnostic and Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Exosome Diagnostic and Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Exosome Diagnostic and Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Exosome Diagnostic and Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Exosome Diagnostic and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 60. NanoSomix Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 61. NX PHARMAGEN Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 62. Malvern Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 63. Capricor Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 64. Exosome Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 65. Exiqon Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 66. System Biosciences Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 67. Aegle Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 68. AMS Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---